Which of the following parts of new drug development does FAERS support?
Post-market surveillance
Phase I
Phase II
Phase III
Post-market surveillance
Rationale: The FDA Adverse Event Reporting System (FAERS) supports post-market surveillance. Its database was designed to support this surveillance in relation to drugs and therapeutic biologic products.
You might also like to view...
You have arrived at a scene where a young girl tripped while running, and pushed her arms through a plate glass window while falling. She is responsive to painful stimuli and has blood spurting from a large laceration on her right upper arm. Your partner yells for you to immediately apply direct pressure to the laceration to prevent further blood loss, while he works to control the airway. You have yet to apply gloves, but your uniform shirt has long sleeves, and you normally wear prescription glasses. What would you do next?
A) Place a tourniquet above the laceration, being careful not to get blood on your hands B) Apply gloves prior to applying direct pressure over the injury site C) Control bleeding by pushing the skin of the laceration together until you can apply gloves D) Apply direct pressure to the site with your forearm until someone with gloves can take over
Lymph is filtered by specialized tissue called:
A. lymphocytes. B. the left lymphatic duct. C. the palatine tonsils. D. lymph nodes.